Strategy
Investing In Women’s Health: The Next Frontier In Wealth Management, Philanthropy
.jpg)
The author of this article argues why women’s health is a wealth management imperative.
This publication has looked at the intersection of health and wealth, in this article for example, from Maryann Umoren Selfe, investment solutions, at Banque Internationale à Luxembourg (Suisse) SA. Maryann is, among other things, a member of this news service’s editorial board. This article touches on how women’s health is also an important wealth management topic. The editors concur and it is fitting to share these ideas ahead of International Women’s Day on 8 March. The usual editorial disclaimers apply to views of guest writers. Email tom.burroughes@wealthbriefing.com and amanda.cheesley@clearviewpublishing.com if you have comments.
A quiet revolution is underway in the world of wealth management.
For decades, the conversation around sustainable investing has
been dominated by climate change, governance reforms, and
corporate diversity. But now, an overlooked and deeply
consequential issue is emerging as the next frontier: women’s
health.
This shift is not happening in a vacuum. At the World Economic
Forum in Davos and the Arab Health Conference this January,
global leaders underscored the economic and social imperative of
improving women’s health outcomes. For wealth managers, the
message is clear: investing in women’s health is not only a
compelling social cause but also a strategic opportunity to
enhance ESG portfolios, deliver long-term returns, and offer
meaningful impact for clients and their families.
The social and economic case for women’s health
investments
Investing in women’s health is more than a moral imperative
– it is a macroeconomic necessity. Research consistently
shows that when women’s health improves, the economic ripple
effects extend far beyond individual wellbeing. A healthier
female workforce leads to higher productivity, stronger GDP
growth, and improved outcomes for future generations.
Take maternal health for example. According to the McKinsey
Health Institute, closing the gender health gap could add up to
$1 trillion to the global economy annually by 2040 (1). For
investors, this presents a unique opportunity: aligning capital
with an issue that is not only socially urgent but also
financially material.
Wealth managers can integrate this into client portfolios by
supporting companies at the forefront of women’s health
innovation. Consider the rise of femtech – a sector
projected to reach $60 billion by 2027 (2). Femtech companies are
redefining how reproductive and maternal healthcare is delivered
through digital solutions. Investors who recognised this trend
early have observed positive market developments, indicating that
women’s health is not a niche cause but an investment thesis with
growth potential.
Women as investors: The rising demand for health-driven
wealth strategies
The growing emphasis on women’s health is not just about the
issues – it’s also about the investors themselves. Women
control an increasing share of private wealth (3), and their
investment preferences are markedly different from those of
previous generations.
A 2022 UBS report found that 79 per cent of women believe it's
important that their investments make a positive impact (4).
Health and wellbeing rank among their top concerns, yet wealth
managers have been slow to tailor their offerings accordingly.
The result? A widening gap between what female investors want and
what traditional wealth services provide.
Family offices and wealth advisors should take note. The demand
for impact-driven financial strategies is not a passing trend but
a structural shift. Forward-thinking firms are already responding
by developing thematic investment portfolios centered on
healthcare equity, funding research into female-specific
conditions, and incorporating gender-lens strategies into ESG
frameworks.
One example is the Women’s Health Innovation Fund, which has
secured backing from private investors and family offices seeking
to accelerate solutions in fertility, menopause, and chronic
disease management. These investors are not sacrificing returns
– they are accessing a high-growth market while aligning
capital with their convictions and participating in a market with
significant growth potential.
Philanthropy as a catalyst: Structuring giving for
maximum impact
Beyond traditional investments, wealth managers have a powerful
lever to drive change: philanthropic structuring. The
misconception that philanthropy and financial returns must
operate separately is fading, giving rise to innovative vehicles
that blend giving with strategic impact.
Take donor-advised funds (DAFs), which allow families to allocate
capital towards women’s health while maintaining investment
flexibility. Fidelity Charitable reported that in 2023, DAF
grants to healthcare initiatives grew by 24 per cent, reflecting
a broader shift towards mission-driven giving. Similarly, private
foundations are increasingly directing capital into
gender-focused health initiatives, from funding clinical trials
for female-specific conditions to supporting access to
reproductive healthcare in underserved regions.
One example of this approach is the Tara Health Foundation, which
deploys capital to improve maternal health and reproductive
rights while integrating impact investing into its endowment
strategy. Such models allow wealth managers to engage clients in
conversations that transcend traditional philanthropy,
positioning them as architects of long-term social and financial
value.
ESG Integration: Avoiding the pitfalls of
box-ticking
For ESG-conscious investors, women’s health presents a natural
fit within the “S” of ESG – but execution matters. Too
often, ESG strategies devolve into a box-ticking exercise,
prioritising vague metrics over substantive impact.
To avoid this pitfall, wealth managers must push beyond
surface-level commitments. One approach is to integrate
gender-disaggregated health data into due diligence processes,
ensuring investments genuinely contribute to better outcomes.
Firms like Equileap have pioneered methodologies for evaluating
gender impact, offering a blueprint for investors who want to go
beyond rhetoric.
Another critical step is shareholder engagement. Large
institutional investors increasingly use their influence to push
companies towards better gender-specific health policies.
BlackRock, for instance, has signalled that workplace healthcare
provisions – especially for women – will be a growing
factor in its stewardship activities. This shift underscores a
key point: investors are no longer passive participants; they are
active drivers of corporate responsibility in health equity.
The future: A paradigm shift in wealth
management
Women’s health is no longer a side issue – it is a core
pillar of wealth management’s future. As wealth holders demand
more purpose-driven investment strategies, and as data continues
to affirm the economic value of gender-inclusive healthcare, the
pressure on wealth managers to evolve will only grow.
The firms that recognise this shift early – by integrating
women’s health into ESG strategies, leveraging philanthropy for
systemic impact, and catering to the rising influence of female
investors – will not only serve their clients better but
will also be on the right side of history.
The question is no longer whether wealth managers should
engage with women’s health, but how soon they will act.
References
(1,2)
https://www.mckinsey.com/mhi/our-insights/closing-the-womens-health-gap-a-1-trillion-dollar-opportunity-to-improve-lives-and-economies
(3)
https://www.mckinsey.com/industries/financial-services/our-insights/women-as-the-next-wave-of-growth-in-us-wealth-management
(4) UBS's 2022 "Own Your Worth" report
The opinions expressed in this article are those of the
author and do not represent the views or positions of any
institution, organisation, or entity with which the author is
affiliated. This article is for informational purposes only
and is not intended as investment advice, financial advice, or a
recommendation to engage in any specific investment
strategy.
All data and figures cited are based on publicly available
information.